简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-06-07 18:51 Oral-B & Crest Encourage Consumers to Brush up on Their Oral Care Regimen and Recognise Its Importance to Overall Body Health
2021-06-04 14:13 ADDING MULTIMEDIA Organon Launches as New Global Women’s Health Company
2021-06-03 10:14 Zayed Sustainability Prize 2022 Expands Global Reach With Submissions From Record 151 Countries
2021-06-03 10:08 Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH
2021-06-03 10:03 Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
2021-06-02 14:19 ZOLL and Global Healthcare SG Sign Exclusive Agreement for Distribution of Portable Targeted Temperature Management System in Asia Pacific
2021-06-02 12:39 DentalMonitoring Continues to Disrupt the Orthodontic Market With AI-powered Solutions for Braces and Aligners of All Brands
2021-06-01 10:00 Mitsubishi Engineering-Plastics Has Developed a Medical Grade Polyacetal Resin, the "Iupital (TM) MA Series"
2021-05-31 19:45 IESE: Corporate Venturing in Deep Tech on the Rise in East and Southeast Asia
2021-05-31 15:26 NEC’s AI Supports Doctors to Detect Neoplasia in Barrett’s Esophagus During Endoscopic Procedures
2021-05-31 10:11 Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases
2021-05-28 09:34 Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
2021-05-28 09:00 BIO KOREA 2021 International Convention to Unlock the Secret of Future Technologies
2021-05-27 15:43 Aptorum Group CEO Subscribed Shares In The Company
2021-05-27 14:22 Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics
2021-05-26 19:09 Rapid Medical Announces Closing of $50m Series D Financing
2021-05-26 09:47 Ferring and Rebiotix Present Positive Interim Phase 3 Results From Open-Label Study of Investigational Microbiota-Based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW)
2021-05-25 19:33 Aptorum Group Announces Positive Interim Phase I Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus and Positive Pre-IND Progress for SACT-1 Targeting Neuroblastoma
2021-05-25 15:14 Seoul Viosys’ Violeds Technology With Proven Virus Disinfection Adopted by SK magic
2021-05-25 12:45 Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection

Business Wire Weibo

Press Releases

Latest Releases